Senate health committee Chair Bernie Sanders (I-VT) released data suggesting weight-loss drugs could soon cost the U.S. health system more than all other drugs combined and he is now asking Denmark to pressure Novo Nordisk to bring its U.S. prices down to those in that country, but industry experts said Thursday (May 16) using international reference pricing could backfire because it could lead to higher prices overseas. Sanders released a report Wednesday (May 15) that suggests the high prices of...